J. Brumberg

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
J Brumberg, J. Brumberg, Joachim Brumberg
Publication record
58 papers · 1,198 citations · H-index 17

PAPERS

Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma
20251 citationsauthor #5
[18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
20255 citationsauthor #1
Neuroimaging in multiple system atrophy: clinical implications and novel developments.
20253 citationsauthor #3
Preserved Serotonin Transporter Availability in Parkinson Disease Measured with Either [11C]MADAM or [11C]DASB: A Study Including 2 Separate Cohorts of Nondepressed Patients
20252 citationsauthor #2
Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study
20249 citationsauthor #9
Voxel‐wise Florzolotau (APN‐1607) Tau PET Covariance Patterns in Alzheimer’s Disease and Progressive Supranuclear Palsy
20240 citationsauthor #2
Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer’s disease
20245 citationsauthor #3
Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases
20244 citationsauthor #1
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
202430 citationsauthor #41
Amphiphysin and GAD65 IgG antibodies in patients with obsessive-compulsive syndromes.
20245 citationsauthor #9
[ <scp> <sup>18</sup> F </scp> ] <scp>PM‐PBB3‐PET</scp> reveals clinical and [ <scp> <sup>18</sup> F </scp> ] <scp>FDG‐PET</scp>
20230 citationsauthor #5
[ 18F]PM‐PBB3‐PET Reveals Clinical and [ 18F]FDG‐PET Mimics of 4‐Repeat Tauopathy Caused by Creutzfeld‐Jakob Disease
20230 citationsauthor #5
Immune-Effector-Cell-Associated-Neurotoxicity-Syndrome (ICANS) Pathophysiology Is Mediated By Microglia TGF-β-Activated Kinase-1 Signaling
20233 citationsauthor #39
Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting as cortisone sensible psychosis with reversible leukoencephalopathy.
20231 citationsauthor #5
Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
20239 citationsauthor #4
Unravelling delayed therapy escape after thalamic deep brain stimulation for essential tremor? – Additional clinical and neuroimaging evidence
20225 citationsauthor #11
Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes
202215 citationsauthor #8
Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites
20225 citationsauthor #1
Frontotemporal dementia associated with intrathecal antibodies against axon initial segments
20223 citationsauthor #11
P 53 Connectivity analysis to predict DBS-induced ataxia in essential tremor
20220 citationsauthor #5
[18F]FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma - A retrospective study.
20224 citationsauthor #12
Reduced Segmentation of Lesions Is Comparable to Whole-Body Segmentation for Response Assessment by PSMA PET/CT: Initial Experience with the Keyhole Approach
20226 citationsauthor #8
New PET radiopharmaceuticals for imaging CNS diseases
20210 citationsauthor #1
Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus
202127 citationsauthor #8
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI
202144 citationsauthor #5
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity
202137 citationsauthor #13
Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
202123 citationsauthor #1
Gait Initiation in Parkinson’s Disease: Impact of Dopamine Depletion and Initial Stance Condition
202048 citationsauthor #6
Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus
202043 citationsauthor #2
FV12 Molecular imaging in the differential diagnosis of parkinsonism: A head-to-head comparison of FDG PET and MIBG scintigraphy
20201 citationsauthor #1
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
202015 citationsauthor #1
Simplified quantification of [18F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
202010 citationsauthor #1
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
202019 citationsauthor #4
Brain metabolic alterations herald falls in patients with Parkinson’s disease
202011 citationsauthor #2
Assessment of biological tumor volume – a relevant prognostic parameter in metastatic prostate cancer?
20200 citationsauthor #4
Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
20209 citationsauthor #1
Clinical utility of different approaches for detection of late pseudoprogression in glioblastoma with O-(2-[18F]fluoroethyl)-L-tyrosine PET
201916 citationsauthor #5
FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
201932 citationsauthor #28
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators
201910 citationsauthor #1
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy
201991 citationsauthor #3
Freezing of gait in Parkinson’s disease reflects a sudden derangement of locomotor network dynamics
2019122 citationsauthor #4
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
201812 citationsauthor #1
Phase matters: A role for the subthalamic network during gait
201842 citationsauthor #6
SPECT Molecular Imaging in Atypical Parkinsonism.
20186 citationsauthor #1
A selective role of striatal dopamine in the timing of anticipatory postural adjustments at gait initiation in patients with Parkinson’s disease
20180 citationsauthor #4
Reply: Clinical approach to delayed-onset cerebellar impairment following deep brain stimulation for tremor.
20175 citationsauthor #3
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease
2017219 citationsauthor #9
Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study
201717 citationsauthor #1
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson’s Disease
201652 citationsauthor #4
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
2016133 citationsauthor #2
[ 123/131 I] azetidinylamide a novel radiotracer for diagnosis and treatment of adrenocortical tumours -- from bench to bedside
20151 citationsauthor #7
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapy.
20151 citationsauthor #2
Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.
201516 citationsauthor #3
Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease
201424 citationsauthor #3
Prediction of relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
20140 citationsauthor #3
Influence of transmission-based attenuation correction on presynaptic dopamine transporter SPECT
20140 citationsauthor #3
Preoperative FDG PET/CT in adrenocortical cancer depicts massive venous tumor invasion.
20142 citationsauthor #3
[Transference interpretations and how they work: a systematic review].
20122 citationsauthor #1

TIMELINE

2012 2 citations

2014 26 citations

2015 18 citations

2016 185 citations

2017 241 citations

2018 60 citations

2019 271 citations

2020 156 citations

2021 131 citations

2022 38 citations

2023 13 citations

2024 53 citations

2025 11 citations

COAUTHOR MAP

CONCEPT FOOTPRINT